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OBJECTIVE — The purpose of this study was to compare the effects of high–
monounsaturated fatty acid (MUFA) and high-carbohydrate (CHO) diets on body weight and
glycemic control in men and women with type 2 diabetes.
RESEARCH DESIGN AND METHODS — Overweight/obese participants with type 2
diabetes (n  124, age  56.5  0.8 years, BMI  35.9  0.3 kg/m
2, and A1C  7.3  0.1%)
were randomly assigned to 1 year of a high-MUFA or high-CHO diet. Anthropometric and
metabolic parameters were assessed at baseline and after 4, 8, and 12 months of dieting.
RESULTS — Baseline characteristics were similar between the treatment groups. The overall
retention rate for 1 year was 77% (69% for the high-MUFA group and 84% for the high-CHO
group;P0.06).Basedonfoodrecords,bothgroupshadsimilarenergyintakebutasigniﬁcant
difference in MUFA intake. Both groups had similar weight loss over 1 year (4.0  0.8 vs.
3.8  0.6 kg) and comparable improvement in body fat, waist circumference, diastolic blood
pressure, HDL cholesterol, A1C, and fasting glucose and insulin. There were no differences in
theseparametersbetweenthegroups.Afollow-upassessmentofasubsetofparticipants(n36)
was conducted 18 months after completion of the 52-week diet. These participants maintained
their weight loss and A1C during the follow-up period.
CONCLUSIONS — In individuals with type 2 diabetes, high-MUFA diets are an alternative
to conventional lower-fat, high-CHO diets with comparable beneﬁcial effects on body weight,
body composition, cardiovascular risk factors, and glycemic control.
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T
he prevalence of type 2 diabetes in
the U.S. continues to increase, in
large part due to rising rates of obe-
sity (1). In fact, the prevalence of diabetes
in obese individuals is 13.6%, 70%
higher than that of the general popula-
tion. Medical nutrition therapy is an inte-
gral component of diabetes management,
but there have been few controlled clini-
cal trials on which to base nutritional rec-
ommendations for individuals with
diabetes. Decreasing the intake of satu-
rated fat and cholesterol with the goal of
decreasingplasmalipidlevelshasbeenan
almost universal prescription for those
withoratriskfordiabetes.Therehasbeen
controversy about whether to replace sat-
urated fat with carbohydrate (CHO) or
monounsaturated fat because evidence
suggests that diets high in monounsatu-
rated fatty acids (MUFAs) may be health-
ier than low-fat, high-CHO diets (2).
High-MUFA diets typical of the Mediter-
ranean region emphasize vegetables,
fruits, whole grains, legumes, nuts, and
olive oil and limit saturated fats from
meat, poultry, and dairy products (3).
Short-term studies (4) have demon-
strated that Mediterranean-type diets im-
prove plasma lipid levels and glycemic
control at least as well as isocaloric high-
CHO diets, without detrimental changes
in triglyceride and HDL cholesterol con-
centrations. Preclinical data support the
notion that increased intake of MUFA,
such as oleate, would have physiological
beneﬁts. Whereas chronic exposure of
pancreatic islets to increased concentra-
tions of fatty acids reduces insulin secre-
tion (5), saturated fatty acids such as
palmitate seem to cause greater rates of
-cell death, whereas oleate has a neutral
or protective effect (6). In addition, al-
though chronically elevated circulating
fatty acids cause insulin resistance, this
effect seems to be more pronounced with
saturated fat than with MUFA (7). Thus,
currentevidencefrominvitroandanimal
studies supports the substitution of
MUFA for saturated fat in diabetic indi-
viduals based on distinct effects on key
parameters of glucose metabolism (8).
A systematic review of Mediterra-
nean-type diet studies (9) identiﬁed only
one published randomized controlled
trial (RCT) with the primary objective of
testing the long-term effects of dieting on
anthropometricparametersinoverweight
and obese adults (10). Recently, a 2-year
RCT examined the effectiveness and
safety of three diets (i.e., Mediterranean,
low-CHO, and low-fat diets) in 300
obese men and women, but this study in-
cludedrelativelyfewdiabeticparticipants
(11). No long-term studies of high-
monounsaturated fatty acids (MUFAs)
diets have speciﬁcally addressed individ-
uals with type 2 diabetes in a non-
Mediterranean area. Therefore, the
objective of the study described here was
to compare the effects of a high-MUFA
diet with a high-CHO, low-fat diet on an-
thropometric and metabolic parameters
inparticipantswithtype2diabetesover1
year.
RESEARCH DESIGN AND
METHODS— Overweight/obese in-
dividuals with moderately well-
controlled type 2 diabetes were recruited
by advertisement. Inclusion criteria were
BMI of 27–40 kg/m
2, age 30–75 years,
stable body weight for the preceding 6
months,diagnosisoftype2diabetesforat
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treatment by diet or oral agents only (no
insulin). Exclusion criteria were preg-
nancy or lactation; active cardiac, pulmo-
nary, renal, liver, or gastrointestinal
disease; untreated thyroid disease or hy-
pertension; triglyceride concentrations
500 mg/dl; and use of medications that
may alter lipid metabolism (other than
HMG-CoA reductase inhibitors), cortico-
steroids, and weight loss drugs.
Allindividualsintheﬁrsttwocohorts
who completed the 52-week intervention
were invited via telephone calls to partic-
ipate in an extension study (i.e., a post-
intervention assessment). All participants
gave informed consent for the study,
which was approved by the University of
Cincinnati and Cincinnati Children’s
Hospital Medical Center institutional re-
view boards.
Assessments
All participant screenings and assess-
ments were conducted at the General
Clinical Research Center of Cincinnati
Children’s Hospital Medical Center by
trained research nurses. At the screening
visit, participants’ height, weight, and
fasting A1C were measured. Height was
measured with a wall-mounted stadiom-
eter to the nearest 0.1 cm. Two height
measurements were obtained and aver-
aged, with a third measurement taken if
the ﬁrst two differed by 0.1 cm. Body
weight was determined to the nearest 0.1
kg on the same properly calibrated elec-
tronic digital scale, without shoes, with
minimal clothing, and after voiding. Two
measurements were taken in immediate
succession and averaged, with a third
measurement taken if the ﬁrst two dif-
fered by 0.1 kg. A1C was analyzed us-
ing a DCA 2000 analyzer.
At the baseline assessment, partici-
pants’ height and weight were measured
again. Waist circumference was deter-
mined by placing a measuring tape in a
horizontal plane around the abdomen
justabovetherightiliaccrest.Threemea-
surements were made to the nearest 0.1
cm and averaged. Blood pressure was
measured using the appropriate size cuff
and a standard mercury sphygmoma-
nometer.Bloodsampleswereobtainedby
venipuncture after a 10-h fast. Total cho-
lesterol, HDL cholesterol, triglycerides,
A1C, glucose, and insulin were measured
usingconventionalmethods.LDLcholes-
terol was determined by calculation (total
cholesterol[HDLcholesteroltriglyc-
erides  5]). Insulin resistance (ho-
meostasis model assessment of insulin
resistance [HOMA-IR]) was calculated as
follows: insulin (units per milliliter) 
glucose (millimoles per liter)  22.5.
Body composition (i.e., body fat and lean
mass) was measured via dual-energy X-
ray absorptiometry using a Hologic
4500Atotalbodyscannerbytrainedtech-
nicians. Reassessment of the baseline
measures was made after 4, 8, and 12
months of dieting.
Extension study
Individuals in the extension study partic-
ipated in an additional assessment that
was conducted 18 months after comple-
tion of the 1-year intervention to deter-
mine whether beneﬁcial changes that
occurred during the intervention were
maintainedovertime,withnocontactbe-
tween the participants and research team.
Bodyweight,height,waistcircumference,
body composition, blood pressure, A1C,
and lifestyle habits were assessed at this
ﬁnal visit.
Diets/activity
After the baseline assessment, partici-
pants were randomly assigned to either a
high-MUFA or a high-CHO diet. Energy
was distributed as 45% CHO, 15% pro-
tein, and 40% fat (with 20% MUFA) in
the high-MUFA diet and as 60% CHO,
15% protein, and 25% fat in the high-
CHO diet. Both diets included similar
amountsofsaturatedfatandprotein.Diet
plans were individualized to include
200–300calories/daylessthancalculated
dailycaloricrequirements(usingtheHar-
ris-Benedictequation),thusallowingfora
moderate weight loss of 	1⁄2 pound/
week.Caloricprescriptionswereadjusted
by the dietitians throughout the study on
the basis of participants’ weight loss and
reported intake.
Each participant was given a meal
plan based on their calorie allotment;
meal plans included 1) food groups with
healthful foods, serving sizes, and num-
berofservingsallowedineachgroup,2)a
list of “free” minimal calorie foods, and 3)
a sample menu. Meal plans included the
following food groups: starches, fruits,
vegetables, low-fat dairy products, meat/
meat substitutes, and fat. Compared with
the high-CHO diet, the high-MUFA diet
included fewer servings of starches, fruit,
andmeat/meatsubstitutesandmoreserv-
ings of fat (emphasizing olive and canola
oils); it also included an additional food
group of beans, legumes, and nuts.
At the onset of the study, participants
were instructed to maintain their level of
physical activity and not to initiate more
vigorous regimens during the 52-week
intervention. If participants were not en-
gaging in physical activity on a regular
basis, they were encouraged to adopt a
walking program of 30 min/day several
days per week.
Diet support
Participants met with a dietitian weekly
during months 1 and 2, biweekly during
months 3 and 4, and monthly during
months5through12foreitherindividual
counselingoragroupsession(alternating
every other visit). To control for possible
bias,eachofthethreestudydietitianswas
assigned participants from each diet
groupforcounselingandalternatedasthe
meeting facilitator for both diet groups.
To monitor food intake, participants kept
detailed 3-day food records during the
weeks of scheduled sessions. Trained re-
search assistants entered the food records
into the nutrition software Food Proces-
sor (ESHA Research; Salem, OR), which
generated reports of the participants’
mean3-dayintakeofenergy,macronutri-
ents, vitamins, minerals, alcohol, and six
foodgroups.Tomonitorphysicalactivity,
participants wore pedometers and re-
corded pedometer readings and physical
activity concurrent with their food
records.
Participants were weighed at each
counseling visit. Group sessions brought
together all participants consuming the
same diet to discuss topics, such as por-
tion control, record keeping, cooking
tips, healthy recipes, and behavior modi-
ﬁcation. During individual sessions, the
dietitians completed a counseling check-
list to enhance consistency of counseling
across sessions and participants. They re-
viewed the participants’ diet and activity
records to ascertain compliance with the
assigneddiet.Thedietitiansratedthepar-
ticipants’ adherence to their regimen on a
scale of 1 to 10 (1  did not follow diet;
10  followed diet all the time); the par-
ticipants estimated their own adherence
on a scale of 1 to 10. Average adherence
ratings were calculated for each partici-
pant. Bivariate and multivariable logistic
regression was used to calculate the odds
ratios (ORs) for completing the study
comparedwithdroppingoutofthestudy.
Statistical analyses
For this study, SAS (version 9.1; SAS In-
stitute, Cary, NC) was used. Before anal-
ysis, the data were examined by
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means, SDs, and other measures. Inten-
tion-to-treat analyses were performed us-
ing estimated values for missing data.
Baseline characteristics were compared
between the two groups using t tests. To
assess the effects of the diets, the anthro-
pometric measures, blood pressure, lipid
measurements, A1C, and plasma glucose
andinsulinwerethedependentvariables,
whereas the independent variable was
diet. For the main analyses, three mixed
models were constructed for each depen-
dent variable, with the covariates of age,
race,sex,andadherencerating.Eachused
a repeated-measure model with no ran-
dom intercepts or random slopes ﬁtted.
Theﬁrstanalysisincludedallthedatacol-
lected, the second model included only
data for those participants who com-
pleted the study, and the third model in-
cluded data for all participants but with
estimates for missing data inserted. Mul-
tiple regression was used for imputation
of missing data with predictive values
based on age, sex, race, and adherence.
Thelevelofsigniﬁcancewassetat0.05for
testing the effects of diet, time, and their
interaction; the interaction was the pri-
mary basis of distinguishing between the
diets. If the interaction was signiﬁcant, an

 level of 0.05 was divided by 3 as the
comparisons of interest were at 4, 8, and
12 months. The results presented in this
article are based on the participants who
completed the intervention (n  95).
However, intention-to-treat analyses us-
ingestimateddataformissingvaluesofall
participants yielded similar results. Data
are presented as means  SEM.
RESULTS
Participant characteristics and
retention
A total of 124 overweight or obese indi-
viduals (46 men and 78 women; 92 Cau-
casians and 32 African Americans) with
type2diabeteswereenrolledinthreesuc-
cessive groups of 32, 48, and 44 partici-
pants. At baseline, participants ranged in
age from 37.9 to 74.9 years, with a
meanSEMageof56.50.8years,BMI
of 35.9  0.3, waist circumference of
111.91.1cm,bodyfatof38.00.6%,
and A1C of 7.3  0.1%, indicative of
moderateglycemiccontrol.Baselinechar-
acteristics did not differ between the diet
groups.
The overall retention rate was 77%,
with 69% for the high-MUFA diet group
and 84% for the high-CHO diet group
(
2  3.65; P  0.06). The majority of
participants who dropped out of the
study (24 of 29) cited relocation, work
schedules, and family responsibilities as
reasons for not attending the counseling
sessions and discontinuing the study.
Only three participants left the study be-
cause of diet-related reasons (i.e., two
high-CHO dieters wanted a lower-CHO
diet and one high-MUFA dieter decided
to follow a higher-protein diet). There
were no differences in sex, race, or age
between participants who completed the
study and those who dropped out of the
study.
Extension study
Of the 57 participants in the ﬁrst two en-
rollment cycles who completed the inter-
vention, 36 (18 from each diet group)
consented to the additional assessment.
These participants were representative of
the intervention study population in
terms of age, race, and adherence ratings.
However, there was a greater ratio of fe-
maletomaleparticipantsintheextension
study than in the intervention study (i.e.,
81 vs. 63% were female).
Adherence
There were no signiﬁcant differences in
adherence ratings between diet groups or
between dietitian and participant ratings
(6.450.21vs.6.670.20forthehigh-
MUFA group; 6.31  0.16 vs. 6.41 
0.16forthehigh-CHOgroup).Whendiet
group, sex, race, and age were controlled,
those participants with higher adherence
ratings were 50% more likely to complete
the study than those with lower adher-
ence ratings (OR  1.5; P  0.012).
Nutrients, foods, and physical
activity
Analyses of 3-day food records indicated
that the participants followed their as-
signed diets. Based on self-report, base-
line caloric intake was similar in both
groups (1,900 vs. 1,984 calories) and
both groups restricted their intake to
	1,550 calories/day throughout the
study. In regard to macronutrients, the
high-MUFA group consumed 46% of to-
tal energy as CHO and 38% as fat; the
high-CHO group consumed 54% of total
energy as CHO and 28% as fat. Both diet
groups consumed comparable amounts
of protein, saturated fat, and cholesterol.
The high-MUFA diet group consumed
signiﬁcantly more total fat, polyunsatu-
rated fat, and MUFA than the high-CHO
diet group (14 vs. 7%, 15 vs. 8%, and 14
vs. 9% of energy as MUFA at 4, 8, and12
months; P  0.001).
At baseline, the participants were
consuming 1.1  0.1 servings from the
dairy group (milk, yogurt, and cheese),
3.90.3servingsfromtheproteingroup
(meat, poultry, ﬁsh, eggs, and dry beans),
7.1  0.3 servings from the starch group
(bread, cereal, rice, and pasta), 2.7  0.2
servingsofvegetables,and1.60.1serv-
ings of fruit. Compared with baseline,
participants in both groups reported sus-
tainedintakeofdairyproducts(1.20.1
servings) during the intervention, de-
creased intake of servings from the pro-
teingroup(3.20.3servings)andstarch
group(5.50.2servings),andincreased
intake of vegetables (3.2  0.2 servings)
andfruits,withthehigh-CHOgroupcon-
suming even more fruit than the high-
MUFA group at 12 months (2.3  0.2 vs.
2.0  0.3 servings; P  0.012).
In regard to speciﬁc foods, partici-
pants following the high-MUFA diet re-
ported increased intake of olive or canola
oils as saute ´s and salad dressings and as
additions to stir-fries, pastas, yogurt,
soup,andoatmeal;avocadosinsaladsand
guacamole; and olives, nuts, seeds, and
legumes (e.g., walnuts, peanuts, sun-
ﬂower seeds, mixed nuts, chick peas, and
beans). In the low-fat diet group, the use
of low-fat versions of salad dressings,
spreads,icecream,andotherproductsin-
creased. Participants in both groups re-
ported increased intake of whole grains,
fruits, and vegetables, particularly salads.
Daily ﬁber intake increased signiﬁcantly
in both diet groups from 17.4  0 . 7ga t
baseline to 20.9  0.9 g at 12 months
(P  0.0001).
Analysis of pedometer readings
showed no differences between diet
groups or over time, indicating that par-
ticipants maintained their baseline activ-
ity during the study.
Anthropometric/metabolic outcomes
Body weight, BMI, waist circumference,
and body fat in the two groups were sim-
ilar at baseline. Both groups had signiﬁ-
cant reductions in weight over 52 weeks
(i.e., 4.0  0.8 and 3.8  0.6 kg in
the high-MUFA and high-CHO diet
groups, respectively; P  0.867) (Table
1), but there was no difference in weight
loss between the diet groups. Likewise,
the reduction in BMI was similar in both
groups after 12 months (1.3 vs. 1.4
kg/m
2; P  0.720). Changes in weight
and BMI were not affected by differences
in age, race, sex, or insulin sensitivity as
Brehm and Associates
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ence rating was a signiﬁcant predictor of
changes in weight and BMI (P  0.01).
Changes in body composition were simi-
lar in both diet groups over time, with
decreased body fat and lean body mass
(P  0.0001) (Table 1) and waist circum-
ference(P0.01).Thereweresigniﬁcant
increases in HDL cholesterol and reduc-
tions in diastolic blood pressure, A1C,
fasting glucose and insulin concentra-
tions, and insulin resistance for both diet
groups over time (P  0.01) but no dif-
ferences in any of these parameters be-
tween the groups (Table 1).
Extension study
There were no signiﬁcant changes in the
participants’ weight, BMI, waist circum-
ference, body fat, blood pressure, or A1C
from the completion of the 52-week diet
to the ﬁnal assessment, 18 months later.
In other words, the participants main-
tained the positive changes that occurred
during the study. Food records revealed
that the participants continued to con-
sume appropriate portions of nutrient-
dense foods and maintained their energy
intake and relative distribution of total
energy as CHO, protein, and fat during
thepostinterventionperiod.However,in-
take of MUFA by the high-MUFA diet
group decreased from 14 to 9% of total
energy.
CONCLUSIONS — This RCT dem-
onstrated comparable beneﬁcial effects of
energy-restricted high-MUFA and high-
CHO, low-fat diets in individuals with
type2diabetes.Ratesofcompletionofthe
1-year study were relatively high, and, on
thebasisoffoodrecords,bothdietgroups
made important modiﬁcations in their
customary intake toward the recom-
mended proportions of MUFA and CHO.
Both diets successfully caused a loss of
	4%ofinitialbodyweightwithimprove-
ment in anthropometric and metabolic
measures. Adherence to either the high-
MUFA or the high-CHO diet predicted
weight loss and body fat reduction. The
results of the extension study suggest that
the weight loss was maintained 18
months after participants completed the
intervention study. These results, the ﬁrst
to test the effectiveness of a high-MUFA
diet over a lengthy period in free-living
diabetic individuals in the U.S., indicate
that either dietary approach can provide
clinicalbeneﬁtsinindividualswithtype2
diabetes.
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ally good metabolic control, with blood
pressure and plasma lipid levels only
mildlyelevatedorneartherecommended
goal. In response to the 1-year interven-
tion, there was a signiﬁcant decrease in
diastolic blood pressure of 4–5 mmHg
and an increase in HDL cholesterol levels
of 	5 mg/dl or 11% in both groups. Fast-
ing insulin and HOMA-IR decreased sig-
niﬁcantly in both groups, consistent with
animprovementininsulinsensitivitythat
was most likely due to weight loss and/or
reduced caloric intake. Reductions of
A1C were similar in both groups, and al-
though much of this effect was lost over
the 12-month period, fasting glucose re-
mained 5–6% lower than at the initiation
of the study. Overall, 75 of the 95 partic-
ipants had improved or stable A1C levels
over the course of the study, whereas 20
individuals had an increase in A1C levels
of at least 0.5%. Thus, despite differences
in macronutrient provision, there were
parallel improvements in glycemia and
insulin sensitivity, indicating that in the
context of tolerable diets and weight loss,
mild variations in nutrient fuels have lim-
itedimpactonglucosemetabolism.How-
ever, the positive effects of both diets on
outcomes in this diabetic cohort were
clinically meaningful in that they would
be expected to improve cardiovascular
risk.
Previous short-term comparisons
(i.e., 6 weeks–3 months) of high-MUFA
and high-CHO diets in overweight or
obese individuals with type 2 diabetes
demonstrated similar weight loss with
both diets (12,13). In an 18-month RCT
of nondiabetic adults comparing energy-
controlled Mediterranean-type and low-
fat diets, participants in both diet groups
lost 	5% of body weight at 12 months
(10). In contrast to our study, only the
Mediterranean diet group was able to
maintaintheirlostweightat18months.A
recent RCT also reported greater weight
loss (	5% of body weight) in the Medi-
terranean diet group compared with the
low-fat diet group after 24 months (11).
Several prior studies indicated that
high-MUFA diets might have metabolic
beneﬁts in individuals with diabetes and
abnormal glucose metabolism. In a meta-
analysis of randomized, crossover trials
involving adults with diabetes, high-
MUFA intake improved fasting glucose,
triglyceride, total cholesterol, and HDL
cholesterol concentrations, but not A1C
or LDL cholesterol levels (4). This report
included highly controlled studies with
metabolic diets, whereas our design fo-
cused on prescribed diets in free-living
individuals. A 2-year RCT of individuals
with metabolic syndrome, conducted in
theMediterraneanregion,showedgreater
improvement in body weight and cardio-
vascular risk factors (e.g., blood pressure,
total cholesterol, HDL cholesterol, trig-
lycerides, insulin resistance, and inﬂam-
matory markers) in a Mediterranean diet
groupcomparedwithalow-fatdietgroup
(14). The results of this trial differed from
ours, possibly because of relative differ-
ences in the health status of the study
populations and distinctions in familiar-
ity, preference, and access to Mediterra-
nean-type foods. In our participants, the
high-MUFA diet presented a greater
change in typical patterns of macronutri-
ent intake than the high-CHO diet, and
the extension study suggests a shift back
to more usual food choices after the inter-
vention was completed.
A signiﬁcant effect on A1C levels may
have been realized with a greater energy
and/or CHO restriction and, subse-
quently, a greater loss of body weight.
Short-term studies have shown that mod-
erateweightloss(i.e.,5%ofbodyweight)
improves glycemia in participants with
type2diabetes(15).Inaddition,boththe
amountandtypeofCHOinﬂuenceglyce-
mic control. A 2-year RCT in individuals
with type 2 diabetes showed improved
BMI and A1C with a CHO-restricted diet
comparedwithaconventionaldiet(45vs.
57% of energy as CHO) (16). In a meta-
analysis of 14 studies with an average du-
ration of 10 weeks, Brand-Miller et al.
(17) demonstrated that low–glycemic in-
dex diets reduced A1C by 0.4% more
than high–glycemic index diets in dia-
betic individuals.
The intense, year-long behavioral in-
tervention delivered by registered dieti-
tians undoubtedly inﬂuenced the dietary
compliance and positive outcomes
achieved by both diet groups. It is inter-
esting to note that the largest amount of
weight loss and improvement in A1C oc-
curred when participants were counseled
on a weekly basis and leveled off as con-
tact with the dietitians became less fre-
quent. In a recent study using dietitian-
led group and individual counseling
sessions, the authors concluded that the
behavioral intervention promoted dietary
adherencetotheMediterraneandietcom-
pared with adherence in a control group
whoreceivedminimaleducation(i.e.,one
session) about a low-fat diet (18). How-
ever, the results of our extension study
imply that at least over time, the partici-
pants were able to adopt lifestyle habits
that sustained the beneﬁcial effects of the
interventionwithoutongoingcounseling.
Althoughthispositiveoutcomeisnottyp-
ical of diet studies, there is evidence that
long-lasting change is possible in moti-
vatedcohorts.Ina3-yearfollow-uptothe
Finnish Diabetes Prevention Study, the
effects of the intervention on weight loss
and lifestyle habits persisted even after
cessation of the counseling intervention
(19).
There are several important limita-
tions to our study. Compliance with pre-
scribeddietsisachallengebothinclinical
trialsandclinicalpractice.Althoughthere
were signiﬁcant differences between the
groups in total fat and MUFA intake, nei-
ther the high-MUFA nor high-CHO
group reached their target goals for
MUFA and CHO intake, respectively.
However, the participants’ self-reported
food records indicate that they were rela-
tively compliant with the diet recommen-
dations. Although there is considerable
documentation of the shortcomings of
self-reporting as a measure of energy in-
take (20), the limited information avail-
able on self-reporting of macronutrients
suggests that macronutrient distribution
is reported more accurately than total in-
take (21). Although we have no biomar-
ker to support the systematic differences
in MUFA intake reported in our groups,
we have no reason to suspect that there
was selective inaccuracy in reporting this
parameter.
The study results are also limited by
the lack of information about the partici-
pants’ drug usage throughout the study
period. In the limited number of partici-
pants (n  32) in which drug usage was
tracked, there were only modest changes,
with no systematic differences between
the diet groups. However, we cannot ex-
clude the possibility that some of the ob-
served changes in weight, A1C, and other
metabolic parameters were inﬂuenced by
concomitant changes in antidiabetes
medication. Finally, we did not perform
sophisticated measures of glucose metab-
olismbutreliedonparameterscommonly
available in the clinic as markers of diet
effects.
To our knowledge, our study is the
ﬁrst long-term RCT to compare the rela-
tive effectiveness of energy-restricted
high-MUFA and high-CHO diets on an-
thropometric and metabolic parameters
speciﬁcally in diabetic individuals in the
U.S. Our study results suggest that high-
Brehm and Associates
DIABETES CARE, VOLUME 32, NUMBER 2, FEBRUARY 2009 219MUFA diets can be healthy alternatives to
conventional lower-fat diets without a
negative impact on body weight, body
composition, cardiovascular risk factors,
or glycemic control. Therefore, practitio-
ners can offer ongoing counseling for a
variety of diets higher in either CHO or
MUFA while controlled in energy. By for-
going the “one size ﬁts all” philosophy
and providing diet options, practitioners
mayenhancepatients’dietarycompliance
and ultimately reduce disease risk.
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